Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Origin and evolution of deep brain stimulation.
4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer.
Crossfit training changes brain-derived neurotrophic factor and irisin levels at rest, after wingate and progressive tests, and improves aerobic capacity and body composition of young physically active men and women.
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.
Cutting Edge: IL-6-Dependent Autoimmune Disease: Dendritic Cells as a Sufficient, but Transient, Source.
Structural connectomics in brain diseases.
Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice.
Deafness in Patients with Multiple Sclerosis.
Stem cell therapy for central nerve system injuries: glial cells hold the key.
The Neuroepithelium Disruption Could Generate Autoantibodies against AQP4 and Cause Neuromyelitis Optica and Hydrocephalus.
Automatic white matter lesion segmentation using an adaptive outlier detection method.
The role of endogenous antiradical protective system in multiple sclerosis.
Curcuminoids in Neurodegenerative Diseases.
The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
OASIS is Automated Statistical Inference for Segmentation, with applications to multiple sclerosis lesion segmentation in MRI.
Multifocal and pattern-reversal visual evoked potentials vs. automated perimetry frequency-doubling technology matrix in optic neuritis.
Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis.
Natalizumab treatment of progressive multiple sclerosis (NAPMS)
Understanding Tremor in Multiple Sclerosis: Prevalence, Pathological Anatomy, and Pharmacological and Surgical Approaches to Treatment.
Impact of multiple sclerosis relapses on progression diminishes with time.
Physician-patient communication skills: e-tools.
No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis.
Mycovirus-like DNA virus sequences from cattle serum and human brain and serum samples from multiple sclerosis patients.
MRI-based clinical trials in relapsing-remitting MS: new sample size calculations based on a longitudinal model.
Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial.

Pages